Insider trades

Vicki L. Sato, Director of Allogene Therapeutics ALLO, has filed 0 purchases and 42 sales on the open market. Over the past 12 months that comes to a net sale of $1.7M. The latest trade was on 06/18.

Vicki L. Sato

Director
First filing
23/01/11
Trades
60 trades
Buys / sales
0 / 42
12-month net buying
−$1.7M
Last trade
06/18

Trading activity

Transactions

Trade type
Open-market sale10b5-1 plan05/0105/0422,000 sh$10.05$221,100−2.0%
Open-market sale10b5-1 plan04/0104/0222,000 sh$9.07$199,540−2.0%
VIR
Open-market sale10b5-1 plan03/0203/0322,000 sh2 trades$9.50avg.$209,096−1.9%
VIR
Open-market sale10b5-1 plan02/2402/2642,377 sh2 trades$9.75avg.$413,277.75−3.6%
Open-market sale10b5-1 plan02/0202/0322,000 sh$7.71$169,620−1.9%
Open-market sale10b5-1 plan01/0201/0522,000 sh$5.93$130,460−1.9%
Open-market sale10b5-1 plan25/12/0125/12/0222,000 sh$6.00$132,000−1.8%
Open-market sale10b5-1 plan25/11/0325/11/0422,000 sh$5.64$124,080−1.8%
Open-market sale10b5-1 plan25/10/0125/10/0222,000 sh$5.84$128,480−1.8%
Open-market sale10b5-1 plan25/09/0225/09/0322,000 sh$4.99$109,780−1.7%
Open-market sale10b5-1 plan25/08/0125/08/0422,000 sh$4.99$109,780−1.7%
Open-market sale10b5-1 plan25/07/0125/07/0222,000 sh$5.10$112,200−1.7%
Open-market sale10b5-1 plan25/01/0825/01/0810,960 sh$12.52$137,219.2−0.8%
Open-market sale10b5-1 plan25/01/0225/01/033,080 sh$20.91$64,402.8−2.8%
Open-market sale10b5-1 plan24/11/0724/11/121,020 sh$30.00$30,600−0.9%
Open-market sale10b5-1 plan24/11/0124/11/053,080 sh$27.07$83,375.6−2.7%
Open-market sale10b5-1 plan24/09/1324/09/161,020 sh$30.00$30,600−0.9%
DNLI
Open-market sale10b5-1 plan24/09/0324/09/043,080 sh2 trades$25.00avg.$77,007.2−2.6%
DNLI
Open-market sale10b5-1 plan24/07/0124/07/033,080 sh2 trades$22.14avg.$68,203.6−2.5%
Open-market sale10b5-1 plan24/05/1524/05/171,674 sh$20.39$34,132.86−1.4%